Launxp Biomedical Co (ROCO:6876) EPS (Basic) : NT$-2.56 (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Launxp Biomedical Co EPS (Basic)?

Launxp Biomedical Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$-1.38. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.56.

Launxp Biomedical Co's EPS (Diluted) for the six months ended in Dec. 2024 was NT$-1.38. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.56.

Launxp Biomedical Co's EPS without NRI for the six months ended in Dec. 2024 was NT$-1.38. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -2.56.

During the past 3 years, the average EPS without NRI Growth Rate was -7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Launxp Biomedical Co's highest 3-Year average EPS without NRI Growth Rate was -7.50% per year. The lowest was -8.80% per year. And the median was -8.15% per year.

Launxp Biomedical Co EPS (Basic) Historical Data

The historical data trend for Launxp Biomedical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Launxp Biomedical Co EPS (Basic) Chart

Launxp Biomedical Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-2.67

-2.06

-2.42

-3.44

-2.56

Launxp Biomedical Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial				-1.44	-1.34	-2.10	-1.18	-1.38

Launxp Biomedical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Launxp Biomedical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-82.595	-	0)	/	32.264
	=	-2.56

Launxp Biomedical Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-44.62	-	0)	/	32.338
	=	-1.38

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.56

Launxp Biomedical Co (ROCO:6876) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Launxp Biomedical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Launxp Biomedical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Launxp Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Launxp Biomedical Co Ltd (ROCO:6876) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408

Website

https://www.launxp.com

Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.

Launxp Biomedical Co Headlines

No Headlines